Patent · US Active

Compositions and methods for treating HCV

US9044480B1 · kind B1 · utility

0Cited by
1References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 5, 2012
Grant dateJun 2, 2015
Priority date
Expiry dateMar 20, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/427
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention features methods of using Compound I to suppress HCV mutants, treat treatment-experienced HCV patients, and treat HCV patients having non-CC IL28B rs12979860 genotype.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.